Sharma said fecal transplantation becomes the best alternative because it is effective in stopping a bad bout of C-Diff. “Eighty-five to 94 percent of patients have a cure with one treatment and ...

C. difficile is difficult to treat and potentially life-threatening in humans. The findings from the study – which was conducted in mice – could lead to the development of new probiotic strategies to ...

difficile, a notoriously difficult-to-treat bacterial infection, according to a team of researchers. The targeted treatment was as effective as human fecal transplants in mice against C.

Investigators at Pennsylvania State University have described a novel approach to combat Clostridioides difficile infection using a synthetic microbiome therapy, which offers an alternative to ...

Recently, more doctors have begun offering fecal transplants. Locally, Kaiser Permanente’s Walnut Creek and Antioch Medical Centers have been treating C. diff patients with fecal transplants for ...

A group of gut bacteria successfully hindered recurrent Clostridium difficile infection in mice, offering alternative therapeutic strategies to antibiotics and fecal transplant. To investigate whether ...

Microbiota transplantation is safe and effective for treating clostridioides difficile infections, according to a clinical trial published in the journal Gastroenterology. Recurrent clostridioides ...

Instead, this microbiome therapy uses fewer but more precise bacteria strains that have been linked to C. difficile suppression. It was as effective as human fecal transplants in mice against C.

The effectiveness of fecal microbiota transplantation in resolving diarrhea associated with C difficile infection is influenced by donor antibiotic use and stool consistency.